Zerumbone (ZER), a
sesquiterpene from the edible plant Zingiber zerumbet Smith, has recently been found to suppress
tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced Epstein-Barr virus activation in a potent manner. In the present study, we evaluated the anti-inflammatory and chemopreventive potentials of ZER in a variety of cell culture experiments. ZER effectively suppressed TPA-induced
superoxide anion generation from both
NADPH oxidase in
dimethylsulfoxide-differentiated HL-60 human
acute promyelocytic leukemia cells and
xanthine oxidase in AS52 Chinese hamster ovary cells. The combined
lipopolysaccharide- and
interferon-gamma-stimulated
protein expressions of
inducible nitric oxide synthase and
cyclooxygenase (COX)-2, together with the release of
tumor necrosis factor-alpha, in RAW 264.7 mouse macrophages were also markedly diminished. These suppressive events were accompanied with a combined decrease in the medium concentrations of
nitrite and
prostaglandin E(2), while the expression level of COX-1 was unchanged. ZER inhibited the proliferation of human colonic
adenocarcinoma cell lines (LS174T, LS180, COLO205, and COLO320DM) in a dose-dependent manner, while the growth of normal human dermal (2F0-C25) and colon (CCD-18 Co) fibroblasts was less affected. It also induced apoptosis in COLO205 cells, as detected by dysfunction of the mitochondria transmembrane,
Annexin V-detected translocation of
phosphatidylserine, and
chromatin condensation. Intriguingly,
alpha-humulene, a structural analog lacking only the carbonyl group in ZER, was virtually inactive in all experiments conducted, indicating that the alpha,beta-unsaturated carbonyl group in ZER may play some pivotal roles in interactions with unidentified target molecule(s). Taken together, our results indicate that ZER is a food
phytochemical that has distinct potentials for use in anti-
inflammation,
chemoprevention, and
chemotherapy strategies.